New preprint online

We just finalised and submitted our comprehensive analysis of Truvada based-PrEP efficacy in women: Synthesis of protective PrEP adherence levels in cis-gender women using convergent clinical and bottom-up modelling. We hope that the work will help to clarify apparent mis-conceptions regarding putative gender-differences in PrEP efficacy and with regards to adherence demands. We would like to thank our collaboration partners for the superb team work and congratulate Lanxin and Sara for their fantastic research. Preprint available here: http://dx.doi.org/0.21203/rs.3.rs-2772765/v1


Posted

in

by

Tags:

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *